ArticlePharmaceuticals (Basel, Switzerland)2022

ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma.

Min Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.